A carregar...
MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart
Cardiovascular disease is the number one cause of morbidity and mortality in the United States. The most common manifestation of cardiovascular disease is myocardial infarction (MI), which can ultimately lead to congestive heart failure (CHF). Cell therap (cardiomyoplasty) is a new potential therape...
Na minha lista:
| Publicado no: | J Cardiovasc Pharmacol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4452997/ https://ncbi.nlm.nih.gov/pubmed/25658461 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FJC.0000000000000183 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|